Cargando…
Allogeneic stem cell transplantation combined with conditioning regimen including donor-derived CAR-T cells for refractory/relapsed B-cell lymphoma
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073016/ https://www.ncbi.nlm.nih.gov/pubmed/36550201 http://dx.doi.org/10.1038/s41409-022-01903-3 |
| _version_ | 1785019500728418304 |
|---|---|
| author | Yang, Fan Shi, Hui Xu, Teng Liu, Rui Lei, Yang Li, Ruiting Deng, Biping Wu, Tong Ke, Xiaoyan Hu, Kai |
| author_facet | Yang, Fan Shi, Hui Xu, Teng Liu, Rui Lei, Yang Li, Ruiting Deng, Biping Wu, Tong Ke, Xiaoyan Hu, Kai |
| author_sort | Yang, Fan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10073016 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-100730162023-04-06 Allogeneic stem cell transplantation combined with conditioning regimen including donor-derived CAR-T cells for refractory/relapsed B-cell lymphoma Yang, Fan Shi, Hui Xu, Teng Liu, Rui Lei, Yang Li, Ruiting Deng, Biping Wu, Tong Ke, Xiaoyan Hu, Kai Bone Marrow Transplant Correspondence Nature Publishing Group UK 2022-12-22 2023 /pmc/articles/PMC10073016/ /pubmed/36550201 http://dx.doi.org/10.1038/s41409-022-01903-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correspondence Yang, Fan Shi, Hui Xu, Teng Liu, Rui Lei, Yang Li, Ruiting Deng, Biping Wu, Tong Ke, Xiaoyan Hu, Kai Allogeneic stem cell transplantation combined with conditioning regimen including donor-derived CAR-T cells for refractory/relapsed B-cell lymphoma |
| title | Allogeneic stem cell transplantation combined with conditioning regimen including donor-derived CAR-T cells for refractory/relapsed B-cell lymphoma |
| title_full | Allogeneic stem cell transplantation combined with conditioning regimen including donor-derived CAR-T cells for refractory/relapsed B-cell lymphoma |
| title_fullStr | Allogeneic stem cell transplantation combined with conditioning regimen including donor-derived CAR-T cells for refractory/relapsed B-cell lymphoma |
| title_full_unstemmed | Allogeneic stem cell transplantation combined with conditioning regimen including donor-derived CAR-T cells for refractory/relapsed B-cell lymphoma |
| title_short | Allogeneic stem cell transplantation combined with conditioning regimen including donor-derived CAR-T cells for refractory/relapsed B-cell lymphoma |
| title_sort | allogeneic stem cell transplantation combined with conditioning regimen including donor-derived car-t cells for refractory/relapsed b-cell lymphoma |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073016/ https://www.ncbi.nlm.nih.gov/pubmed/36550201 http://dx.doi.org/10.1038/s41409-022-01903-3 |
| work_keys_str_mv | AT yangfan allogeneicstemcelltransplantationcombinedwithconditioningregimenincludingdonorderivedcartcellsforrefractoryrelapsedbcelllymphoma AT shihui allogeneicstemcelltransplantationcombinedwithconditioningregimenincludingdonorderivedcartcellsforrefractoryrelapsedbcelllymphoma AT xuteng allogeneicstemcelltransplantationcombinedwithconditioningregimenincludingdonorderivedcartcellsforrefractoryrelapsedbcelllymphoma AT liurui allogeneicstemcelltransplantationcombinedwithconditioningregimenincludingdonorderivedcartcellsforrefractoryrelapsedbcelllymphoma AT leiyang allogeneicstemcelltransplantationcombinedwithconditioningregimenincludingdonorderivedcartcellsforrefractoryrelapsedbcelllymphoma AT liruiting allogeneicstemcelltransplantationcombinedwithconditioningregimenincludingdonorderivedcartcellsforrefractoryrelapsedbcelllymphoma AT dengbiping allogeneicstemcelltransplantationcombinedwithconditioningregimenincludingdonorderivedcartcellsforrefractoryrelapsedbcelllymphoma AT wutong allogeneicstemcelltransplantationcombinedwithconditioningregimenincludingdonorderivedcartcellsforrefractoryrelapsedbcelllymphoma AT kexiaoyan allogeneicstemcelltransplantationcombinedwithconditioningregimenincludingdonorderivedcartcellsforrefractoryrelapsedbcelllymphoma AT hukai allogeneicstemcelltransplantationcombinedwithconditioningregimenincludingdonorderivedcartcellsforrefractoryrelapsedbcelllymphoma |